IH

Ishtiyaq Hussain

Active Director Director DIN 09482527
DIN 09482527 First appointment Jan 2022 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2022
Shareholding value •••• Premium profile

About Ishtiyaq Hussain

Data last updated:

Ishtiyaq Hussain is a Director at Alig Pharma Private Limited (since 2022). The company operates in Healthcare. Alig Pharma Private Limited reported revenue of ₹2 Lakh (FY 2025).

DIN 09482527
Primary Designation Director
Industry Healthcare
First Appointment 28 Jan 2022
Oldest Company Age 4 yrs
Largest company Alig Pharma Private Limited · ₹2 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Alig Pharma Private Limited U85100DL2022PTC392947
Director28 Jan 20222022₹2 Lakh (FY 2025)Active

Board colleagues of Ishtiyaq Hussain

NameDINCompanyDesignation
Mohd Arif10538175Alig Pharma Private LimitedAdditional Director
Mubeen09482526Alig Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Alig Pharma Private Limited
Premium access

Shareholding and investment profile for Ishtiyaq Hussain

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ishtiyaq Hussain

Ishtiyaq Hussain currently holds 1 directorship: Alig Pharma Private Limited (Director, since 28 Jan 2022, revenue ₹2 Lakh (FY 2025)).

Ishtiyaq Hussain was first appointed on 28 Jan 2022 as Director at Alig Pharma Private Limited.

The current boards of Ishtiyaq Hussain's companies include Mohd Arif (Alig Pharma Private Limited), Mubeen (Alig Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available